Literature DB >> 25082288

Semaphorins and plexins as therapeutic targets.

Thomas Worzfeld1, Stefan Offermanns2.   

Abstract

Semaphorins are membrane-bound or diffusible factors that regulate key cellular functions and are involved in cell-cell communication. Most of the effects of semaphorins are mediated by plexins. Work over the past decade has revealed crucial functions of the semaphorin-plexin system in mammalian physiology. It has also become clear that semaphorins and plexins have important roles in many pathophysiological processes, including cancer, immunological diseases and bone disorders, and that they represent novel targets for drugs to prevent or treat various diseases. This Review summarizes the functions of the mammalian semaphorin-plexin system as well as its role in diseases and discusses emerging strategies to pharmacologically target semaphorin-plexin signalling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25082288     DOI: 10.1038/nrd4337

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  198 in total

1.  Unified nomenclature for the semaphorins/collapsins. Semaphorin Nomenclature Committee.

Authors: 
Journal:  Cell       Date:  1999-05-28       Impact factor: 41.582

Review 2.  Immunological functions of the neuropilins and plexins as receptors for semaphorins.

Authors:  Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

3.  Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.

Authors:  Diane R Bielenberg; Yasuhiro Hida; Akio Shimizu; Arja Kaipainen; Michael Kreuter; Caroline Choi Kim; Michael Klagsbrun
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

4.  Semaphorin 7A is a negative regulator of T cell responses.

Authors:  Agnieszka K Czopik; Margaret S Bynoe; Noah Palm; Cedric S Raine; Ruslan Medzhitov
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

Review 5.  Semaphorin receptors meet receptor tyrosine kinases on the way of tumor progression.

Authors:  G Cagnoni; L Tamagnone
Journal:  Oncogene       Date:  2013-11-11       Impact factor: 9.867

6.  Gene deletion mutants reveal a role for semaphorin receptors of the plexin-B family in mechanisms underlying corticogenesis.

Authors:  A Hirschberg; S Deng; A Korostylev; E Paldy; M R Costa; T Worzfeld; P Vodrazka; A Wizenmann; M Götz; S Offermanns; R Kuner
Journal:  Mol Cell Biol       Date:  2009-11-30       Impact factor: 4.272

Review 7.  Semaphorin function in neural plasticity and disease.

Authors:  R Jeroen Pasterkamp; Roman J Giger
Journal:  Curr Opin Neurobiol       Date:  2009-06-21       Impact factor: 6.627

8.  Structural basis of semaphorin-plexin signalling.

Authors:  Bert J C Janssen; Ross A Robinson; Francesc Pérez-Brangulí; Christian H Bell; Kevin J Mitchell; Christian Siebold; E Yvonne Jones
Journal:  Nature       Date:  2010-09-26       Impact factor: 49.962

9.  Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells.

Authors:  G M Argast; C H Croy; K L Couts; Z Zhang; E Litman; D C Chan; N G Ahn
Journal:  Oncogene       Date:  2009-06-01       Impact factor: 9.867

10.  Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.

Authors:  Andrea Casazza; Boaz Kigel; Federica Maione; Lorena Capparuccia; Ofra Kessler; Enrico Giraudo; Massimiliano Mazzone; Gera Neufeld; Luca Tamagnone
Journal:  EMBO Mol Med       Date:  2012-01-13       Impact factor: 12.137

View more
  105 in total

1.  Pax6 organizes the anterior eye segment by guiding two distinct neural crest waves.

Authors:  Masanari Takamiya; Johannes Stegmaier; Andrei Yu Kobitski; Benjamin Schott; Benjamin D Weger; Dimitra Margariti; Angel R Cereceda Delgado; Victor Gourain; Tim Scherr; Lixin Yang; Sebastian Sorge; Jens C Otte; Volker Hartmann; Jos van Wezel; Rainer Stotzka; Thomas Reinhard; Günther Schlunck; Thomas Dickmeis; Sepand Rastegar; Ralf Mikut; Gerd Ulrich Nienhaus; Uwe Strähle
Journal:  PLoS Genet       Date:  2020-06-17       Impact factor: 5.917

2.  Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents.

Authors:  Iratxe Zuazo-Gaztelu; Marta Pàez-Ribes; Patricia Carrasco; Laura Martín; Adriana Soler; Mar Martínez-Lozano; Roser Pons; Judith Llena; Luis Palomero; Mariona Graupera; Oriol Casanovas
Journal:  Cancer Res       Date:  2019-06-25       Impact factor: 12.701

3.  DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.

Authors:  Jana Jeschke; Martin Bizet; Christine Desmedt; Emilie Calonne; Sarah Dedeurwaerder; Soizic Garaud; Alexander Koch; Denis Larsimont; Roberto Salgado; Gert Van den Eynden; Karen Willard Gallo; Gianluca Bontempi; Matthieu Defrance; Christos Sotiriou; François Fuks
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

Review 4.  Axon formation, extension, and navigation: only a neuroscience phenomenon?

Authors:  Shannon K Rich; Jonathan R Terman
Journal:  Curr Opin Neurobiol       Date:  2018-09-21       Impact factor: 6.627

Review 5.  Divergent roles of Plexin D1 in cancer.

Authors:  Sneha Vivekanadhan; Debabrata Mukhopadhyay
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

Review 6.  Structural mechanisms of plexin signaling.

Authors:  Heath G Pascoe; Yuxiao Wang; Xuewu Zhang
Journal:  Prog Biophys Mol Biol       Date:  2015-03-28       Impact factor: 3.667

7.  Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice.

Authors:  Anamika Singh; Masum M Mia; Dasan Mary Cibi; Ashutosh Kumar Arya; Sanjay Kumar Bhadada; Manvendra K Singh
Journal:  J Biol Chem       Date:  2019-04-12       Impact factor: 5.157

8.  Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential.

Authors:  Sreeharsha Gurrapu; Emanuela Pupo; Giulia Franzolin; Letizia Lanzetti; Luca Tamagnone
Journal:  Cell Death Differ       Date:  2018-03-19       Impact factor: 15.828

9.  PKC induces release of a functional ectodomain of the guidance cue semaphorin6A.

Authors:  Riley M St Clair; Caroline M Dumas; Kori S Williams; Matthew T Goldstein; Elizabeth A Stant; Alicia M Ebert; Bryan A Ballif
Journal:  FEBS Lett       Date:  2019-08-16       Impact factor: 4.124

10.  Inhibition of semaphorin-3a suppresses lipopolysaccharide-induced acute kidney injury.

Authors:  Xiaofang Tian; Hua Gan; Yizhou Zeng; Hongfei Zhao; Rong Tang; Yunfeng Xia
Journal:  J Mol Med (Berl)       Date:  2018-06-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.